We use cookies to make it easier for you to use our website and give you a better experience. We aggregate the information we get through cookies from users like you, and analyze that data to better understand user behavior and help us improve the website. We do not give or sell the data you provide through cookies to any third party for any purpose (such as advertising or marketing). By using this website, you consent to Organogenesis using cookies for these purposes. You may change your settings anytime by clicking on the “Security” tab on your browser. Note that Organogenesis is located in the United States, and the U.S. has not yet been determined to have “adequate” data privacy safeguards by the EU; despite any inherent risks in the transfer of data from the EU, Organogenesis takes the security of your information seriously. To read our privacy policy, click here.
Apligraf® Contact UsApligraf® ContactApligraf® Signup for Information and News.

The field of wound care is changing and evolving all the time. If you would be interested in hearing the latest information and news on Apligraf®, please sign up below for future emails from Organogenesis Inc.

All fields marked with an asterisk * are required.

! Some errors were found. Please correct the fields indicated below:
First name:*
Last name:*
Address 1:*
Address 2:
Wound care condition:  Diabetic Foot Sore    Venous Leg Sore
I would like to offer my opinions and feedback by being included in future wound care marketing research studies.
(Please note, that these are not clinical studies).
I would like to be sent information and updates on Apligraf®.
Enter code shown
in the picture
on the right:*
(not case sensitive)
To Enlarge Click on Image
Click to enlarge this image
Display different code




Your name, address, and any other personally identifiable information you provide will be available to Organogenesis and companies working for Organogenesis, which have agreed not to release your information to anyone else. Organogenesis will not disclose your information to anyone other than these companies, except as required by law. Organogenesis, and companies working for Organogenesis, will use this information to provide you with useful information, respond to your inquiries and to perform data analysis and program evaluation. We may also provide you with new and updated information about this program. Your information will not be used for any other purpose. In the future, we may send you new and updated information about this program. You understand this authorization will expire ten (10) years from the date specified below.


3. Falanga V, Sabolinski ML. A bilayered living skin construct (Apligraf®) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7:201-207.

4. Veves A, Falanga V, et al. Graftskin, a human skin equivalent, is effective in management of non-infected neuropathic diabetic foot ulcers. Diabetes Care. 2001;24:290-295